Foresite Capital Management V
Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PRDS, THRX, SLGC, ACRS, HIMS, and represent 69.80% of Foresite Capital Management V's stock portfolio.
- Added to shares of these 2 stocks: HIMS (+$5.3M), ENTA.
- Started 1 new stock positions in ENTA.
- Reduced shares in these 4 stocks: SLGC (-$13M), HLTH, CGEM, ADGI.
- Foresite Capital Management V was a net seller of stock by $-12M.
- Foresite Capital Management V has $245M in assets under management (AUM), dropping by -39.84%.
- Central Index Key (CIK): 0001792206
Tip: Access up to 7 years of quarterly data
Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Foresite Capital Management V
Companies in the Foresite Capital Management V portfolio as of the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Pardes Biosciences (PRDS) | 27.7 | $68M | 9.4M | 7.22 | ||
| Theseus Pharmaceuticals (THRX) | 15.1 | $37M | 3.2M | 11.53 | ||
| Somalogic Com Cl A (SLGC) | 12.2 | $30M | -30% | 3.7M | 8.02 | |
| Aclaris Therapeutics (ACRS) | 8.9 | $22M | 1.3M | 17.24 | ||
| Hims & Hers Health Com Cl A (HIMS) | 5.9 | $14M | +58% | 2.7M | 5.33 | |
| Adicet Bio (ACET) | 5.5 | $14M | 680k | 19.97 | ||
| Quantum-Si Incorporated Com Cl A (QSI) | 4.5 | $11M | 2.3M | 4.68 | ||
| Cullinan Oncology (CGEM) | 4.2 | $10M | -13% | 993k | 10.47 | |
| Kinnate Biopharma (KNTE) | 4.0 | $9.9M | 875k | 11.26 | ||
| Adagio Therapeutics (ADGI) | 2.7 | $6.5M | -17% | 1.4M | 4.56 | |
| Compass Therapeutics (CMPX) | 2.5 | $6.0M | 4.4M | 1.37 | ||
| Research Alliance Corp. II Com Cl A (RACB) | 2.0 | $4.9M | 500k | 9.76 | ||
| Gemini Therapeutics (GMTX) | 1.4 | $3.4M | 2.4M | 1.39 | ||
| Cue Health (HLTH) | 1.3 | $3.2M | -57% | 491k | 6.45 | |
Setup an alertForesite Capital Management V will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Enanta Pharmaceuticals (ENTA) | 1.2 | $3.0M | NEW | 42k | 71.17 | |
| 23andMe Holding Com Cl A (ME) | 0.6 | $1.6M | 407k | 3.83 | ||
| Pharvaris N V (PHVS) | 0.3 | $619k | 34k | 18.13 | ||
Past Filings by Foresite Capital Management V
SEC 13F filings are viewable for Foresite Capital Management V going back to 2020
- Foresite Capital Management V 2022 Q1 filed May 13, 2022
- Foresite Capital Management V 2021 Q4 filed Feb. 11, 2022
- Foresite Capital Management V 2021 Q3 filed Nov. 12, 2021
- Foresite Capital Management V 2021 Q2 filed Aug. 16, 2021
- Foresite Capital Management V 2021 Q1 filed May 17, 2021
- Foresite Capital Management V 2020 Q4 filed Feb. 16, 2021